As one of the world’s leading private healthcare provider, IHH stands at the forefront of delivering exceptional care to patients in the markets that we operate in. Our esteemed reputation and trusted brands not only garner widespread recognition, but also draws the attention of the investment community and stakeholders alike. We spare no effort in helping our shareholders and other stakeholders understand the business and foster confidence with the effective use of various communication platforms. Through a meticulously orchestrated mix of platforms, ranging from regulatory disclosures to digital channels, we ensure that every piece of information regarding IHH’s corporate milestones, financial, operational, and clinical achievements is disseminated promptly and accurately. Material company announcements are made through Bursa Malaysia (Bursa) and the Singapore Exchange (SGX), as well as on our corporate website and social media channels, providing timely, accurate and comprehensive information. The Annual Report and Annual General Meeting (AGM) channels also present comprehensive yearly reviews and promote interaction with our shareholders respectively. The financial resilience of IHH was prominently showcased when we declared significant dividends for FY2023, reflecting our strong operational performance and robust financial strategy. These dividends underscore our ongoing commitment to delivering shareholder value and affirming investor confidence in our strategic direction. Noteworthy Initiatives Highlighting our proactive approach to stakeholder engagement, the investor relations (IR) team organised an insightful visit to Acibadem in Türkiye in October 2023. This initiative provided an exclusive platform for analysts and media to gain a comprehensive understanding of our operational nuances and strategic foresight, reinforcing IHH’s standing in this market. At this visit, we hosted over 20 analysts, fund managers and members of the media from Malaysia and Singapore. Our guests visited Acibadem’s best- in-class medical facilities and had a behind-the-scenes tour of our facilities. In addition, they had exclusive meetings with the founder and Chairman of the Acibadem Healthcare Group, Mr Mehmet Ali Aydinlar, and his management team to understand the company ethos and Acibadem’s unique strengths within the IHH portfolio. Through thorough discussions and interactions with Acibadem’s leadership and operations team on the ground, our guests gleaned valuable insights into Acibadem’s exceptional care and service, and gained a good overview of the Turkish healthcare system. Our newly reported laboratories segment, since the start of 2023, was also a point of interest among analysts and stakeholders. In June 2023, we organised a visit to Premier Integrated Labs, our leading medical diagnostic laboratory in Malaysia, to provide a transparent view of our operations and the strategic potential that lies within, aligning with our commitment to operational excellence and innovation. Further, as part of our IR efforts, we hold regular engagements with the stock exchanges in Malaysia and Singapore to keep abreast of the latest laws and requirements. We continue to be a Champion for the Bursa Malaysia Public Listed Companies Transformation (PLCT) programme. The programme aims to increase the attractiveness of listed companies in Malaysia by strengthening the growth narratives of publicly listed companies across all sizes. HealthcareInsider Event In July 2023, we held the sixth episode of IHH’s flagship HealthcareInsider event – Healthcare 2.0: Unleashing The Power Of Disruptive Innovations. Our host and panellists led a thought-provoking discussion on the power of disruptive innovations like artificial intelligence and their implications on the healthcare space. The event attracted over 200 attendees on-site and online, including shareholders, staff, business partners, members of the public and the media. In the past year, IHH has continued to strengthen its position as a leading healthcare provider on the global stage. Our unwavering commitment to excellence and transparency has further deepened stakeholders’ trust in IHH. We consistently work towards fostering stronger engagement, ensuring our stakeholders remain well-informed about our robust operational framework and strategic initiatives. Our proactive multi-channel approach ensures timely and accurate dissemination of news and announcements, promoting transparency in our relationship with stakeholders. Annual Report 2023 119 Investor Relations Report
RkJQdWJsaXNoZXIy NDgzMzc=